Your browser doesn't support javascript.
loading
Activation of the Unfolded Protein Response (UPR) Is Associated with Cholangiocellular Injury, Fibrosis and Carcinogenesis in an Experimental Model of Fibropolycystic Liver Disease.
Chen, Chaobo; Wu, Hanghang; Ye, Hui; Tortajada, Agustín; Rodríguez-Perales, Sandra; Torres-Ruiz, Raúl; Vidal, August; Peligros, Maria Isabel; Reissing, Johanna; Bruns, Tony; Mohamed, Mohamed Ramadan; Zheng, Kang; Lujambio, Amaia; Iraburu, Maria J; Colyn, Leticia; Latasa, Maria Ujue; Arechederra, María; Fernández-Barrena, Maite G; Berasain, Carmen; Vaquero, Javier; Bañares, Rafael; Nelson, Leonard J; Trautwein, Christian; Davis, Roger J; Martinez-Naves, Eduardo; Nevzorova, Yulia A; Villanueva, Alberto; Avila, Matias A; Cubero, Francisco Javier.
Afiliação
  • Chen C; Department of Immunology, Ophthalmology and ENT, Complutense University School of Medicine, 28040 Madrid, Spain.
  • Wu H; 12 de Octubre Health Research Institute (imas12), 28041 Madrid, Spain.
  • Ye H; Department of General Surgery, Wuxi Branch of Zhongda Hospital, Southeast University, Wuxi 214105, China.
  • Tortajada A; Department of Hepatic-Biliary-Pancreatic Surgery, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing 210008, China.
  • Rodríguez-Perales S; Department of Immunology, Ophthalmology and ENT, Complutense University School of Medicine, 28040 Madrid, Spain.
  • Torres-Ruiz R; Department of Immunology, Ophthalmology and ENT, Complutense University School of Medicine, 28040 Madrid, Spain.
  • Vidal A; Department of Anesthesia, Zhongda Hospital, Southeast University, Nanjing 210008, China.
  • Peligros MI; Department of Immunology, Ophthalmology and ENT, Complutense University School of Medicine, 28040 Madrid, Spain.
  • Reissing J; 12 de Octubre Health Research Institute (imas12), 28041 Madrid, Spain.
  • Bruns T; Molecular Cytogenetics and Genome Editing Unit, Human Cancer Genetics Program, Centro Nacional de Investigaciones Oncológicas (CNIO), 28029 Madrid, Spain.
  • Mohamed MR; Molecular Cytogenetics and Genome Editing Unit, Human Cancer Genetics Program, Centro Nacional de Investigaciones Oncológicas (CNIO), 28029 Madrid, Spain.
  • Zheng K; Laboratorio de Investigación Traslacional (LRT1)-ProCURE, Institut Català d'Oncologia (ICO)-IDIBELL, L'Hospitalet de Llobregat, 08908 Barcelona, Spain.
  • Lujambio A; Institute of Pathology, Hospital Universitario Gregorio Marañon, 28007 Madrid, Spain.
  • Iraburu MJ; Department of Internal Medicine III, University Hospital RWTH, 52074 Aachen, Germany.
  • Colyn L; Department of Internal Medicine III, University Hospital RWTH, 52074 Aachen, Germany.
  • Latasa MU; Department of Internal Medicine III, University Hospital RWTH, 52074 Aachen, Germany.
  • Arechederra M; Department of Immunology, Ophthalmology and ENT, Complutense University School of Medicine, 28040 Madrid, Spain.
  • Fernández-Barrena MG; Liver Cancer Program, Division of Liver Diseases, Department of Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
  • Berasain C; The Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
  • Vaquero J; Graduate School of Biomedical Sciences at Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
  • Bañares R; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
  • Nelson LJ; Department of Biochemistry and Genetics, University of Navarra, 31008 Pamplona, Spain.
  • Trautwein C; Hepatology Program, Cima, University of Navarra, 31008 Pamplona, Spain.
  • Davis RJ; Hepatology Program, Cima, University of Navarra, 31008 Pamplona, Spain.
  • Martinez-Naves E; Hepatology Program, Cima, University of Navarra, 31008 Pamplona, Spain.
  • Nevzorova YA; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Instituto de Salud Carlos III, 28029 Madrid, Spain.
  • Villanueva A; Instituto de Investigaciones Sanitarias de Navarra-IdiSNA, 31008 Pamplona, Spain.
  • Avila MA; Hepatology Program, Cima, University of Navarra, 31008 Pamplona, Spain.
  • Cubero FJ; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Instituto de Salud Carlos III, 28029 Madrid, Spain.
Cancers (Basel) ; 14(1)2021 Dec 24.
Article em En | MEDLINE | ID: mdl-35008241
ABSTRACT
Fibropolycystic liver disease is characterized by hyperproliferation of the biliary epithelium and the formation of multiple dilated cysts, a process associated with unfolded protein response (UPR). In the present study, we aimed to understand the mechanisms of cyst formation and UPR activation in hepatocytic c-Jun N-terminal kinase 1/2 (Jnk1/2) knockout mice. Floxed JNK1/2 (Jnkf/f) and Jnk∆hepa animals were sacrificed at different time points during progression of liver disease. Histological examination of specimens evidenced the presence of collagen fiber deposition, increased α-smooth muscle actin (αSMA), infiltration of CD45, CD11b and F4/80 cells and proinflammatory cytokines (Tnf, Tgfß1) and liver injury (e.g., ALT, apoptosis and Ki67-positive cells) in Jnk∆hepa compared with Jnkf/f livers from 32 weeks of age. This was associated with activation of effectors of the UPR, including BiP/GRP78, CHOP and spliced XBP1. Tunicamycin (TM) challenge strongly induced ER stress and fibrosis in Jnk∆hepa animals compared with Jnkf/f littermates. Finally, thioacetamide (TAA) administration to Jnk∆hepa mice induced UPR activation, peribiliary fibrosis, liver injury and markers of biliary proliferation and cholangiocarcinoma (CCA). Orthoallografts of DEN/CCl4-treated Jnk∆hepa liver tissue triggered malignant CCA. Altogether, these results suggest that activation of the UPR in conjunction with fibrogenesis might trigger hepatic cystogenesis and early stages of CCA.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2021 Tipo de documento: Article